dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2015-10-21T13:09:46Z
dc.date.available2015-10-21T13:09:46Z
dc.date.created2015-10-21T13:09:46Z
dc.date.issued2015-06-01
dc.identifierResearch In Veterinary Science. Oxford: Elsevier Sci Ltd, v. 100, p. 176-181, 2015.
dc.identifier0034-5288
dc.identifierhttp://hdl.handle.net/11449/128425
dc.identifier10.1016/j.rvsc.2015.03.001
dc.identifierWOS:000356558100027
dc.description.abstractThe epithelial mesenchymal transition (EMT) is a fundamental event responsible for the invasiveness and metastasis of epithelial tumours. The EMT has been described in many human cancers, but there are few reports of this phenomenon in veterinary oncology. Due to the importance of this process, the current study evaluated mesenchymal and epithelial marker protein expression in prostate lesions from dogs. Our results indicate both a loss of E-cadherin and translocation of P-catenin from the membrane to the cytoplasm and nucleus in the tumour group. Vimentin expression in the tumour group was higher than in normal tissue. All of the metastases were positive for prostate-specific antigen, pan-cytokeratin and E-cadherin, although fewer positive cells were present than in the primary tumours. The immunohistochemical results showed a loss of epithelial markers and a gain of a mesenchymal marker among metastatic cells, suggesting that the EMT occurs during the metastatic process of canine prostate carcinoma. (C) 2015 Elsevier Ltd. All rights reserved.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationResearch In Veterinary Science
dc.relation1.616
dc.relation0,593
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectDog
dc.subjectProstate cancer
dc.subjectImmunohistochemistry
dc.subjectEpithelial-mesenchymal crosstalk
dc.titleEvidence of epithelial-mesenchymal transition in canine prostate cancer metastasis
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución